AIDS News and Research

RSS

New initiative to improve HIV health outcomes for Black men who have sex with men

The results of a multi-year initiative aimed at improving HIV health outcomes for Black men who have sex with men (MSM) are published in a new Supplement in the peer-reviewed journal AIDS Patient Care and STDs.

27 Oct 2022

$3 million grant to support the expansion of Midwest AIDS Training and Education Center at UIC

The Midwest AIDS Training and Education Center at the University of Illinois Chicago will expand its services nationwide with the help of a new $3 million grant.

26 Oct 2022

Researchers fabricate a non-porous biodegradable vascular graft

Researchers developed a novel small-diameter biodegradable vascular graft that aids the formation of elastin-containing structures in the intima-media, which is important for the normal functioning of the artery.

26 Oct 2022

The acceptability of a language support system by nurses

At the end of a working day, nurses have covered quite a few kilometers. They would like to save themselves some of the trips. Voice assistants might help do just that.

21 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

What do pandemic preparedness, mental health care services, and over-the-counter hearing aids have in common? They are all things President Joe Biden touted on the campaign trail this week as he tries to maintain Democrats' majorities in Congress in the midterm elections Nov. 8.

20 Oct 2022

Why do some people attract mosquitoes more than others?

Mosquitoes (e.g., Aedes aegypti) are common vectors for many viruses that infect the human population, such as dengue, Zika, and yellow fever.

19 Oct 2022

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Massachusetts General Hospital and Brigham and Women's Hospital, the founding members of Mass General Brigham, today announced their participation in STOMP (Study of Tecovirimat for Human Monkeypox Virus), a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat (TPOXX) for the treatment of human monkeypox.

19 Oct 2022

Medically tailored meals could result in net cost savings of $13.6 billion each year

Adopting more programs that make and deliver medically tailored meals to people with serious, diet-sensitive diseases could result not only in improved health outcomes in the form of fewer hospitalizations nationally, but in a net cost savings of approximately $13.6 billion each year, according to new research from the Friedman School of Nutrition Science and Policy at Tufts University.

17 Oct 2022

Danish researchers take an important step in finding a cure for HIV

For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation.

17 Oct 2022

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Researchers presented an overview of factors influencing emerging infectious diseases. They also highlighted the importance of molecular dynamic (MD) simulations and molecular docking (MDO) analysis for combating these diseases.

17 Oct 2022

Physical exercise provides positive health benefits on COVID-19 outcomes

A new study found that physical exercise has a positive effect on the coronavirus disease 2019 (COVID-19) prognosis.

17 Oct 2022

Say what? Hearing aids available over-the-counter for as low as $199, and without a prescription

Starting Monday, consumers will be able to buy hearing aids directly off store shelves and at dramatically lower prices as a 2017 federal law finally takes effect.

17 Oct 2022

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

In a recent study published in the International Journal of Infectious Diseases, researchers assessed the efficacy of coronavirus disease 2019 (COVID-19) vaccines in people living with human immunodeficiency virus (HIV).

16 Oct 2022

Certain types of dietary fiber fuel inflammation in some people with inflammatory bowel disease

People who suffer from inflammatory bowel disease may soon have access to personalized dietary guidelines to keep them feeling well, thanks to new research on how dietary fibre affects the disease.

13 Oct 2022

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivity

Researchers from Ireland used human bronchial epithelium models to evaluate the ability of a novel proprietary formulation called ViruSAL to inhibit SARS-CoV-2 infections.

12 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022

AIDS News and Research

New initiative to improve HIV health outcomes for Black men who have sex with men

$3 million grant to support the expansion of Midwest AIDS Training and Education Center at UIC

Researchers fabricate a non-porous biodegradable vascular graft

The acceptability of a language support system by nurses

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

Why do some people attract mosquitoes more than others?

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Medically tailored meals could result in net cost savings of $13.6 billion each year

Danish researchers take an important step in finding a cure for HIV

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Physical exercise provides positive health benefits on COVID-19 outcomes

Say what? Hearing aids available over-the-counter for as low as $199, and without a prescription

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

Certain types of dietary fiber fuel inflammation in some people with inflammatory bowel disease

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivity

Duke receives federal funding for HIV vaccine research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News